PTC Therapeutics Inc at Jefferies Healthcare Conference Transcript
Good afternoon, everyone. Thank you for attending Jefferies New York Healthcare Conference. My name is Kelly Shi, one of the biotech analysts here.
And please join me and welcome Dr. Matthew Klein, CEO; and also Ms. Kylie O'Keefe, CCO of PTC Therapeutics for this fireside chat session. And we will discuss where is the company working on at the moment, and what are the most exciting progress recently. Maybe we'll start from there, especially for the investors who're not super familiar with the company. Welcome.
Sure, Kelly. Thank you so much. It's great to be here. For some background on PTC, PTC has celebrated its 25th anniversary. We are a biopharmaceutical company and discovers and develops and commercializes therapies for patients with rare disorders.
We began 25 years ago to focus on RNA biology and have grown to have several scientific platforms that are highly innovative and have yielded a number of different differentiated products. We currently have five
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
